Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 2 of 15

→ World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad)
Slide 2
Back to 1
Continue to 3
 
Back to 1
Continue to 3
 

United Therapeutics (NASDAQ:UTHR)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
8 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$294.25 (25.2% Upside)

About United Therapeutics

United Therapeutics logoUnited Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
3/7/2024Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$309.00 ➝ $325.00
2/22/2024WedbushReiterated RatingOutperform ➝ Outperform$308.00
2/22/2024HC WainwrightReiterated RatingBuy ➝ Buy$300.00
2/12/2024The Goldman Sachs GroupUpgradeSell ➝ Neutral$213.00 ➝ $215.00
2/5/2024Leerink PartnrsReiterated RatingOutperform
2/5/2024SVB LeerinkInitiated CoverageOutperform$330.00
12/8/2023Wells Fargo & CompanyInitiated CoverageOverweight$309.00
11/2/2023Morgan StanleyLower Price TargetOverweight ➝ Overweight$318.00 ➝ $314.00
11/2/2023JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$290.00 ➝ $294.00
11/2/2023WedbushReiterated RatingOutperform ➝ Outperform$307.00 ➝ $308.00
Slide 2
Back to 1
Continue to 3
 

World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Click here to find out what to do.

More From MarketBeat
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
from Colonial Metals
7 Stocks Under $20 You Won’t Want to Miss
from MarketBeat
The A.I. story nobody is telling you (Read ASAP)
from TradeSmith
10 Best Penny Stocks to Buy Now
from MarketBeat
This Apple-like Innovator is Revolutionizing Healthcare
from Wall Street Star
10 Cheap Dividend Stocks to Buy Today
from MarketBeat